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AbstrAct
Objective Provision of a discharge care plan and 
prevention therapies is often suboptimal. Our objective was 
to design and pilot test an interdisciplinary, organisational 
intervention to improve discharge care using stroke as the 
case study using a mixed-methods, controlled before–after 
observational study design.
setting Acute care public hospitals in Queensland, 
Australia (n=15). The 15 hospitals were ranked against 
a benchmark based on a composite outcome of three 
discharge care processes. Clinicians from a ‘top-ranked’ 
hospital participated in a focus group to elicit their success 
factors. Two pilot hospitals then participated in the 
organisational intervention that was designed with experts 
and consumers.
Participants Hospital clinicians involved in discharge 
care for stroke and patients admitted with acute stroke or 
transient ischaemic attack.
Intervention A four-stage, multifaceted organisational 
intervention that included data reviews, education and 
facilitated action planning.
Primary and secondary outcome measures Three 
discharge processes collected in Queensland hospitals 
within the Australian Stroke Clinical Registry were 
used to select study hospitals: (1) discharge care plan; 
(2) antihypertensive medication prescription and (3) 
antiplatelet medication prescription (ischaemic events 
only). Primary measure: composite outcome. Secondary 
measures: individual adherence changes for each 
discharge process; sensitivity analyses. The performance 
outcomes were compared 3 months before the intervention 
(preintervention), 3 months postintervention and at 
12 months (sustainability).
results Data from 1289 episodes of care from the 
two pilot hospitals were analysed. Improvements from 
preintervention adherence were: antiplatelet therapy 
(88%vs96%, p=0.02); antihypertensive prescription 
(61%vs79%, p<0.001); discharge planning (72%vs94%, 
p<0.001); composite outcome (73%vs89%, p<0.001). 
There was an insignificant decay effect over the 
12-month sustainability period (composite outcome: 89% 
postintervention vs 85% sustainability period, p=0.08).
conclusion Discharge care in hospitals may be effectively 
improved and sustained through a staged and peer-
informed, organisational intervention. The intervention 
warrants further application and trialling on a larger scale.
IntrOductIOn
In terms of the total global burden of disease, 
neurological disorders combined with cere-
brovascular disease represents 7.1% for all 
causes and ages.1 Stroke contributes to the 
majority of this burden, and similar to other 
chronic neurological conditions, patients are 
hospitalised for acute treatment. A hospital 
strengths and limitations of this study
 ► Hospitals offer the ideal environment to instigate 
individualised prevention management strategies 
for chronic conditions with a high risk of recurrence, 
such as stroke. However, few effective interventions 
are available to improve recommended and high-
quality discharge care. A strength of this research is 
that is has begun to fill this important knowledge–
practice gap.
 ► The organisational intervention was carefully 
designed using theory, evidence, involvement 
of consumers and a broad range of clinical and 
implementation sciences experts.
 ► Standardised and routinely collected data from a 
national clinical quality registry were used to ensure 
reliable comparisons over time, including ability to 
measure the long-term sustainability impact, the 
new frontier in quality improvement.
 ► The effectiveness data (n=1289 episodes of care) 
were obtained from two hospitals and trialling in a 
larger number of hospitals to confirm the findings 
is needed.
 ► Similar to other non-randomised studies, there is the 
potential for reporting and response bias.
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provides the ideal environment in which to instigate indi-
vidualised prevention management strategies for chronic 
neurological conditions with a high risk of recurrence, 
such as stroke where the cumulative 10-year risk is about 
40%.2 3
Because of the sudden impact of chronic disability 
that may be a consequence of stroke, comprehen-
sive discharge planning, that involves the patient and 
family, is recommended to facilitate transition back into 
the community. The objective of interdisciplinary and 
formalised discharge planning is to reduce length of stay, 
improve the coordination of services following discharge 
and avoid readmission and long-term unmet needs.4 5 
Unfortunately, evidence from national stroke audits and 
the Australian Stroke Clinical Registry (AuSCR) consis-
tently show that less than three in five patients receive 
a discharge care plan or behavioural prevention educa-
tion from clinicians, and prescription of prevention 
medication is suboptimal.6 7 This is despite the avail-
ability of standardised tools to help clinicians undertake 
these activities more efficiently in Australia such as the 
Stroke Foundation’s ‘My Stroke Journey’ discharge pack 
that comprises an education booklet and care planning 
guide.8 A better understanding of clinician and hospital 
factors related to discharge care is needed to support the 
development of more effective interventions that target 
clinician practice to ensure optimal discharge care.9 10
The aims of this study were to design and pilot test 
an interdisciplinary, organisational intervention to 
improve discharge care using stroke as the case study. In 
particular, we sought to determine the preliminary effec-
tiveness of the new intervention using routinely collected 
data from the AuSCR by comparing preimplementation 
and postimplementation adherence results (combined 
as a composite outcome and for individual processes of 
care) and the change in performance relative to bench-
marks established for these processes across the different 
measurement periods (ie, referred to here as a change 
in performance gap score). We also sought to measure 
sustainability of any improvements over a 12-month time 
period, as sustainability outcomes are rarely reported.11–13 
The primary outcome was the net change in the overall 
composite outcome and secondary outcomes were changes 
in individual scores and the gap score. Further details are 
provided below.
MethOds
The description and reporting of our intervention is based 
on the Standards for QUality Improvement Reporting 
Excellence 2.0 guidelines to promote completeness of 
information, transparency and potential for replication 
in the field.14
context
Acute care public hospitals located in Queensland and 
using the AuSCR for performance monitoring were the 
setting for the intervention. Discharge care involves 
different health professionals.5 In acute hospitals, where 
there is a high turnover of beds and short lengths of stay 
(average for stroke is about 5 days),7 omissions may occur. 
Designing interventions for achieving behaviour change 
can be challenging when health professionals are time 
poor or where roles and responsibilities for different 
aspects of care are shared. Furthermore, it remains 
unclear if multifaceted organisational interventions are 
more effective than single-component interventions or 
whether there is a dose–response relationship.15
Intervention development and design
This was a mixed-methods study that was iteratively 
undertaken whereby results of each stage were reviewed 
to inform the next stage.16 The basis of the intervention 
was to use external facilitation to raise awareness of areas 
of underperformance with local clinicians and workup 
strategies to leverage enabling factors and reduce barriers 
to successful implementation of the discharge processes 
relevant to the local context. The intervention develop-
ment and pilot testing occurred over a 5-month period. A 
summary of each phase is provided below with additional 
detail provided in the online Supplemental methods.
Preintervention design phase: understanding what works well at 
‘top-performing’ hospitals
We included a preintervention design phase whereby two 
hospitals with the greatest adherence to the discharge 
processes were selected to provide information on the 
factors that made provision of discharge care successful 
at their site. These were defined as ‘top-performing’ or 
‘exemplar’ hospitals. Qualitative data from these exem-
plar hospitals were subjected to thematic analysis and the 
factors that were found to influence adherence to the clin-
ical care processes were mapped across the 14 domains 
of the theoretical domains framework (TDF).17 18 This 
provided a conceptual basis for describing the enablers 
and barriers to implementation.
Intervention design phase
The intervention was designed using complementary 
knowledge translation concepts and theory including 
elements of the ‘Promoting Action on Research Imple-
mentation in Health Services’ (PARIHS) framework, 
transtheoretical model of change; the plan–do–study–
act method and the Ottawa model of research use.9 19–22 
In an attempt to fast track strategy development at the 
pilot hospitals, successful techniques reported from the 
‘exemplar’ hospitals were shared (online supplemental 
results, table I). An expert working group (n=9) that 
included decision-makers, clinicians, experts in knowl-
edge translation and consumer representatives finalised 
the intervention with the project team via one face-to-face 
workshop and two teleconferences.
The final intervention, known as STELAR (Shared Team 
Efforts Leading to Adherence Results), was delivered in four 
discrete stages: pre-workshop survey (to gain a better under-
standing of current discharge processes and practices); 
two facilitated workshops (workshop 1: to discuss aspects of 
existing practices and gather consensus on the potential 
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Figure 1 Project stages and evaluation periods.
barriers that could be modified; workshop 2: an educa-
tion component delivered by a ‘local opinion leader’ 
followed by a review of local AuSCR performance data 
by the external facilitator (DAC) and then develop-
ment of a local action plan and appointment of a local 
‘change champion’ who would facilitate implementation 
of the agreed strategies. The strategies aimed to maxi-
mise use of existing resources and processes, rather than 
increasing staff workloads) and ongoing telephone/electronic 
support by the programme team for 2 months after the 
second workshop. During this time, retraining in AuSCR 
data collection processes was also provided, as required. 
(figure 1 and online supplemental methods,  figure I). A 
staged approach was used to improve knowledge of capa-
bility, motivation and opportunity within the settings, 
which have been recognised as fundamental to under-
standing the targeted behaviours.23 In brief, the delivery 
mechanisms included external facilitation; performance 
feedback with a gap analysis and a codesigned educa-
tional meeting using a local opinion leader, evidence 
from exemplar hospitals and a structured action planning 
activity. Participants were hospital staff involved in deliv-
ering the discharge processes including medical, nursing, 
pharmacy and allied health clinicians to be identified by 
the local opinion leader. The majority of these delivery 
mechanisms were informed by the literature.17 19 24
Measures of intervention effectiveness
Hospital performance was measured using patient-level 
data entered into the AuSCR by clinicians at participating 
hospitals using a standardised approach.25 In brief, all 
patients admitted to hospital with stroke or transient 
ischaemic attack (TIA) are eligible to be included in this 
national clinical quality registry and an opt-out proce-
dure is used, or waiver of consent for people who die in 
hospital, to reduce selection bias. Clinical performance 
data collected in relation to discharge care as part of the 
AuSCR in Queensland are: (1) provision of a discharge 
care plan developed with the interdisciplinary team and 
the patient and/or family; (2) prescribed antihyperten-
sive medication at discharge from hospital or (3) if an 
ischaemic stroke or TIA, prescribed antiplatelet/antico-
agulant medications at discharge from hospital.7 For a 
full description refer to online supplementary table II .
The primary effectiveness outcome used in this study 
was a composite score of adherence to each of the three 
discharge processes combined from both hospitals 
(referred to as the overall composite outcome). Adherences 
to individual processes were also evaluated, as was adher-
ence relative to benchmarks for each of the processes and 
the composite outcome (referred to as performance ‘gap’ 
score) (see the Data analysis section and online supple-
mentary figure II). Results from individual hospitals and 
in combination are presented.
Selection of hospitals
Public hospitals in Queensland that had registered at 
least 20 patients in the AuSCR between January 2012 and 
June 2013 were eligible (n=15; 82%). The two exemplar 
hospitals were chosen from sites that fell within the top 
20th percentile for the composite gap score.
To pilot test this new intervention, we selected two hospi-
tals that would benefit from improvement in adherence to 
these care processes (referred to here as ‘pilot hospitals’) 
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and these were chosen from sites that fell within the 
bottom 20th percentile (online supplemental methods, 
figure III). One and half years of data were used to ensure 
that we identified sites with consistently high or low levels 
of performance. We also interrogated the data from the 
selected pilot sites to ensure that their results were not 
an artefact of missing or poorly entered data. As more 
than two hospitals met the criteria, hospital selection 
was also based on: relative performance across the indi-
vidual care processes; the extent to which the hospital 
was representative of other similar hospitals to improve 
the generalisability of the results and ability to partici-
pate within our project time frame. Stroke unit medical 
directors of the eligible hospitals were sent an invitation 
letter in January 2014 and then consent to participate was 
obtained.
ethical considerations
The project was approved by the Metro North Hospital 
and Health Service, The Prince Charles Hospital Human 
Research Ethics Committee (HREC/13/QPCH/279, 
November 2013) and governance approval was obtained 
from each participating hospital. Approval for the project 
was also granted by the AuSCR Research Task Group and 
governance committees.
data analysis
Assessment of hospital performance for discharge care
Adherence of each hospital to the care processes was 
calculated as the number of patients who received the 
discharge process divided by the number of patients who 
were eligible for the care process. The composite outcome 
was calculated as the total number of patients who 
received the three discharge processes divided by the 
total number of patients eligible to receive the three care 
processes. Benchmarks were also calculated for each care 
process, based on a modified version of the Achievable 
Benchmarks of Care approach26 previously used in stroke 
by Hall et al,27 whereby the benchmark is calculated using 
at least 15% of the data.
The benchmarks were then used to calculate a gap 
score for each hospital for each discharge process and the 
composite outcome. To calculate this, adherence scores 
were divided by the relevant benchmark to provide the 
gap score (eg, if a site had an adherence score of 40% and 
the benchmark was 80%, the gap score would be 50% as 
they would be halfway towards meeting the benchmark) 
(online supplementary figure II provides an overview of 
the equations used). Separate benchmarks were calcu-
lated, using data from all 15 hospitals, for deriving the 
gap scores for each evaluation period. This approach 
accounted for the potential influence of other quality 
improvement activities being undertaken in Queensland 
between the different time periods used in the analyses 
and secular trends, as well as reducing issues of ceiling 
effects associated with individual care processes.
Changes in performance over time
Analysis of patient-level AuSCR data was used to deter-
mine the effectiveness of the intervention applying a 
historically controlled before–after design comparing 
the composite outcome scores. Time periods compared 
were: 3 months prior to the commencement of the 
intervention (preintervention period January to March 
2014); 3 months after workshop 2 (postintervention 
period, October to December 2014) and 12 months after 
the postintervention period to assess if the programme 
had sustained effects (sustainability period, October to 
December 2015). Logistic regression was used to obtain 
ORs related to the proportion of patients who received 
each of the individual care processes at a site level. For 
the combined scores, we used multilevel analysis, with the 
levels defined as patient and hospital, to adjust for correla-
tions between patients within hospitals. A secondary 
analysis was performed comparing the gap scores, and 
a sensitivity analysis was also performed to describe the 
differences between the baseline period (January 2012 
to June 2013) and postintervention period (October to 
December 2014).
Descriptive statistics including Χ2 tests for comparisons 
of proportions between the different evaluation periods 
were used. Level of significance was set at p<0.05.
results
Each invited hospital agreed to participate. Overall, 1298 
episodes of care from the two pilot sites were included in 
the analysis (pre=419; post=438 and sustainability=432). 
Both pilot sites had a stroke unit which included co-lo-
cated beds within a geographically defined ward staffed 
by a dedicated, multidisciplinary team with expertise in 
stroke. Site 1 was a 400-bed hospital and a regional hub 
for three small referring rural hospitals (catchment popu-
lation 400 000). Site 2 was a 530-bed regional hospital 
providing services for a population of approximately 
240 000 people, as well as tertiary-referral services for 
another 670 000. Site 1 admits approximately 450 patients 
with stroke and TIA per annum and site 2 admits approx-
imately 250. Both offer a 24/7 thrombolysis service. Site 
1 has a rapid-access TIA service staffed by a multidisci-
plinary team which can provide early rehabilitation. Both 
pilot hospitals have access to subacute and inpatient 
rehabilitation services. These hospitals are typical of most 
hospitals in Queensland contributing data to AuSCR.
Table 1 provides a summary of identified modifiable 
barriers that were common to both pilot hospitals, broadly 
described based on need for evidence, the context of care 
or where facilitation might be required. Common themes 
included habituation of practice and awareness of prac-
tice gaps. More specifically, inconsistent use of existing 
tools and systems, lack of pharmacist involvement as part 
of interdisciplinary care, inconsistent procedural knowl-
edge associated with discharge planning, such as clinicians 
making assumptions about patient eligibility independent 
of other evidence, and suboptimal recording of data in the 
AuSCR and medical records were consistent areas iden-
tified for improvement. Importantly, it was recognised 
that existing processes and administrative systems could 
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be leveraged by changing workflow processes. Common 
strategies included providing an example of a compre-
hensive discharge care plan for clinicians to refer to, 
using reminders (such as stickers in medical records) to 
facilitate prescription of medications, and regular reviews 
of data at team meetings. The health professionals also 
planned to empower patients and their families to use the 
My Stroke Journey8 pack that was to be provided at time 
of admission to promote more effective and collaborative 
discharge care planning. There was recognition that when 
such interactions with patients and families occurred, this 
needed to be documented.
Intervention effectiveness
Patient characteristics were generally similar from the 
participating hospitals relative to the non-participating 
hospitals during the preintervention and postinterven-
tion periods (online supplementary table III). Some 
exceptions were ability to walk on admission (site 2: 
pre 25%, post 75%, p<0.001 site 1: pre 50%, post 35%, 
p=0.04). The median age preintervention was 76 (Quan-
drant (Q)1 25th percentile: 67, Q3 75th percentile: 84) at 
site 1, 66 at site 2 (Q1: 58, Q3: 77) and 73 (Q1: 61, Q3:81) 
for the other Queensland sites combined. The propor-
tion of women in the preintervention period was 43% 
for site 1, 44% for site 2% and 42% for non-participating 
sites, and the proportion of ischaemic stroke were 71% 
for site 1, 67% for site 2% and 68% for non-participating 
sites. There were some differences in discharge destina-
tions with site 1 commencing initial subacute care within 
the stroke unit in approximately one-third of patients 
compared with none at site 2%, and 7% of non-partici-
pating sites.
Overall, the postintervention composite outcome 
(89%) significantly improved compared with the prein-
tervention result from pilot sites (73%; p<0.001). This 
was mainly attributable to greater provision of discharge 
care plans which had the greatest scope for improvement 
(72% preintervention vs 94% postintervention) (table 2). 
Sustainability was achieved for all but one care process 
(prescribed antiplatelet therapy at discharge) which had 
a significant 7% reduction in adherence at 12 months 
after the intervention. A small non-significant reduction 
of 4% in the composite outcome occurred at 12 months 
(89% postintervention vs 85% at 12 months) representing 
the decay effect. Significant overall improvements were 
also achieved when the overall benchmark-derived gap 
scores were compared for the composite outcome (prein-
tervention composite gap score 85% vs postintervention 
94% p<0.001) and maintained during the 12-month 
sustainability period. Other results on the changes in 
different gaps scores are provided in online supplemen-
tary table IV.
Despite overall improvements in the composite outcome 
and individual care processes, there were variations in 
the magnitude of improved performance between the 
pilot sites following the STELAR intervention (table 2). 
Results from our sensitivity analyses comparing the 
baseline (hospital selection period) composite outcome 
and postintervention outcomes showed much greater 
improvements than comparisons between the preinter-
vention and postintervention periods, and in contrast to 
the non-participating hospitals (site 1, baseline composite 
outcome 37%; postintervention 86%, p<0.001 and site 2, 
baseline composite outcome 44%; postintervention 93%, 
p<0.001) (figure 2 and online supplementary figure IV).
dIscussIOn
Changing clinician behaviour to improve patient care 
will ultimately lead to better patient outcomes.10 19 24 28 
The results from this project provide promising data on a 
new, theory and evidence-informed, multifaceted organ-
isational intervention for improving discharge care after 
hospitalisation for acute stroke. Overall, significant and 
sustained improvements in adherence to the discharge 
processes were demonstrated following implementa-
tion of the STELAR programme. The net change in the 
composite outcome increased 16% after implementation 
with a non-significant decay effect at 12-month postim-
plementation (12% improvement compared with the 
preimplementation result or 4% decay effect). This case 
study in stroke is relevant to other neurological chronic 
conditions and provides information to support clinicians 
in how to design or deliver an organisational intervention 
that can be tailored to the local context.
The final design of the intervention included several 
stages since knowledge translation for healthcare profes-
sionals is more likely to be successful if stakeholders are 
involved in the process; readiness for change is achieved 
and the approach is informed by an assessment of the 
likely barriers and facilitators.10 29 Each pilot site had a 
change champion appointed, and we also used a local 
opinion leader to deliver the educational component of 
the face-to-face workshop. This is because local opinion 
leaders can influence rapid uptake of evidence.18 Similar 
to other authors,30 we found mapping the reported 
barriers and enablers to the TDF18 and corresponding 
behaviour change techniques17 to be a comprehensive 
approach to support targets for inclusion in an effective 
intervention. A particularly novel aspect was using expe-
rience from ‘exemplar hospitals’ to inform selection of 
strategies for inclusion in action plans.
The results are encouraging and accord with the most 
promising effect sizes for similar types of interventions 
reported in systematic reviews.10 24 If this intervention is 
considered a form of ‘audit and feedback’ methodology, 
then the feedback component we provided was consis-
tent with the literature on the most effective methods 
for achieving a large effect. Feedback may be more effec-
tive when baseline performance is low; the provider of 
the feedback is a supervisor or a colleague; the data on 
performance are provided more than once and in verbal 
and written formats; and when it includes explicit targets 
and an action plan.19 Each of these elements was used in 
STELAR and provides further evidence that an absolute 
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Figure 2 Overall changes in adherence across different time periods for the pilot sites and non-participation 
hospitals. STELAR, shared team efforts leading to adherence results.
risk difference of 16%, consistent with the reported 
upper IQR from the included studies in the Ivers and 
colleagues’ review,19 is reproducible.
Strengths of our study include use of routinely collected 
and standardised data available from an established 
national clinical quality registry, the AuSCR, which facil-
itates routine and prospective monitoring and quality 
improvement.31 Importantly, we also incorporated 
reporting of sustainability, the new frontier in quality 
improvement.11 12 The programme was informed by the 
literature including relevant theoretical frameworks and 
systematic reviews of effective strategies to achieve clini-
cian behaviour change. Each of the theoretical frameworks 
we used included the common elements of performance 
review against the evidence; and barrier management that 
takes into account local context or attempts to assess or 
account for the level of adoption.9 32 33 Previous authors 
have summarised the factors needed for successful knowl-
edge translation, which include preparing for change, 
capacity for implementation including people and setting, 
resources, leverage, desirable implementation enabling 
features and achieving sustainability.34 Importantly, our 
design provided the possibility to align intervention 
components with the transtheoretical model of behaviour 
change: precontemplation (site identification—awareness 
raising), contemplation (recognising the gaps and consid-
ering possible causes (workshop 1)), preparing for action 
(action plan and change champion appointed), action 
(action plan implementation with external support) and 
maintenance (sustainability review) of change.22
Limitations included the potential for bias associated 
with observational studies, including reporting and 
response bias. Despite strong engagement with, and 
uptake of, the intervention at both sites, variability in 
the degree of change in adherence to the care processes 
at each site postintervention was noted (net change in 
composite outcome site 1: 7% and site 2: 33%). This 
may have been partly due to ceiling effects for some 
of the processes and the time delay between enrolment 
(when sites were made aware of potential for underper-
formance) and commencement of the interventions. 
This meant that sites were aware of the project 2 months 
prior to the start of the baseline data collection period 
and 9 months prior to the commencement of the inter-
vention. Both sites had improved adherence between 
the baseline (hospital selection) and preintervention 
phase (net change in composite outcome site 1: 42% 
and site 2: 16%). Although we did not openly disclose 
if the hospital was an exemplar or pilot site at the time 
of the initial invitation, all could access online summary 
performance reports from the AuSCR at any time. The 
invitation may have prompted them to review their data. 
Other external factors such as presentation of data at 
the annual Queensland Stroke Clinical Network Forum 
in November 2013 may also have motivated efforts to 
improve discharge care, as the benchmark thresholds 
increased over time. If ‘awareness raising’ (invitation 
at baseline period) had been accounted for as part of 
the intervention, the overall results would have been 
more pronounced as demonstrated in the sensitivity 
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analysis (both sites shifted 49 percentage points from 
baseline (invitation) to postintervention). Encourag-
ingly, further improvements occurred and by the end 
of the study, both pilot sites were among the top-per-
forming hospitals in Queensland for the measured care 
processes. We also acknowledge that the low baseline 
scores for the intervention pilot sites may have resulted 
in some regression towards the mean in our results. 
However, the magnitude of change in our pre-scores and 
post-scores was large and so would have been unlikely 
to have impacted on the significance of our results. 
We also acknowledge that type 1 errors from testing of 
multiple associations or outcomes may be possible, but 
given our large effect sizes (>2) and our small p-values, 
type 1 errors in our primary outcome, change in the 
combined composite score, are unlikely.35
In the area of stroke and other neurological condi-
tions, few examples of interventions designed to 
effectively change clinician behaviour exist. These 
include multifaceted interventions such as the Get-With-
The-Guidelines-Stroke programme36 37 and the Quality in 
Acute Stroke Care Trial that was a nurse-led intervention 
to improve management of fever, sugar and swallowing in 
acute stroke units through use of protocols.38 39 Similarly, 
there is a paucity of evidence for the hospital setting on the 
sustainability of practice improvement programmes. In a 
recent scoping review, only seven studies of programme 
sustainability had been conducted within a hospital 
environment.11 In our future planned work, it will be 
important to determine if this proposed STELAR inter-
vention is reproducible in more hospitals, and can be 
extended to other care processes. We are currently under-
taking a step-wedge designed study among 12 hospitals 
located in Victoria (Australia) where this type of inter-
vention has not previously been used following funding 
obtained from the Ian Potter Foundation in 2016.
In conclusion, improving discharge care in hospitals 
through a staged, evidence-based, multifaceted interven-
tion was effective and sustainable, and further testing of 
the intervention in more hospitals would be worthwhile. 
Importantly, we drew on the cumulative experience from 
the growing field of knowledge translation to design a 
programme for stroke, where little previous research has 
been undertaken. This research is relevant to other clin-
ical domains, where variation in practice for discharge 
care is widespread.
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